A significant reduction in cancer death rates has been observed in the U.S. over the past 35 years. According to a report from the American Association for Cancer Research, these rates have fallen by 35%, equating to nearly 5 million fewer cancer deaths since 1991. This improvement is largely due to increased screening and advancements in cancer treatments.
Inequitable Progress
Despite these overall gains, progress is not uniform across different racial and ethnic groups. African American communities, as well as American Indian and Alaska Native populations, exhibit the highest overall cancer death rates. This results in elevated incidence and mortality rates for various cancers in these groups.
Black individuals in the U.S. have historically had higher cancer death rates compared to white individuals, though this gap has narrowed somewhat. Currently, Black people face nearly twice the likelihood of dying from conditions like multiple myeloma, stomach, prostate, and gallbladder cancers compared to white individuals. Breast cancer mortality rates are 35% higher among Black women than white women. Additionally, colorectal cancer, which is increasingly affecting individuals under 50, has higher mortality rates among Black and American Indian/Alaska Native populations than among white people.
Impact of Screening
Screening, particularly for colorectal cancer, has played a substantial role in reducing cancer deaths. A reported 79% of averted colorectal cancer deaths are linked to increased screening efforts. During procedures like colonoscopies, doctors can remove precancerous polyps, averting potential cancer growth. People of average risk are recommended to begin screenings at age 45. However, the report highlights that screening rates are lower among non-white populations.
In 2023, 53% of Hispanic people and 57% of Asian and American Indian/Alaska Native individuals were up to date on colonoscopies, compared to 67% of white individuals. The Hispanic community faces the largest increases in early-onset colorectal cancer, with annual rises of 4.7% among women and 3.7% among men.
Real-Life Experiences
Alex Valdez, diagnosed with colorectal cancer at 38, exemplifies the challenges faced by younger individuals. Despite experiencing no symptoms for years, a necessary colonoscopy for his ulcerative colitis and Crohn’s disease led to the discovery of a 7-centimeter tumor. His experience underscores the importance of early screenings to detect cancer during treatable stages.
Cervical Cancer Disparities
Cervical cancer screening rates remain lower among Asian and Hispanic women compared to white women. Women in economically disadvantaged counties also face lower rates of regular screening. Death rates from cervical cancer are disproportionately higher in these counties.
Dr. Sarah Kim, a gynecologic surgeon, notes significant barriers faced by socially disadvantaged people, such as the inability to access healthcare regularly. Yet, cervical cancer is preventable through the HPV vaccine, accessible at local pharmacies without a prescription.
Underlying Causes of Disparities
Various factors contribute to disparities in cancer diagnoses and mortality, including systemic racism and social, economic, and physical conditions impacting health and quality of life. These factors influence not only screening and diagnosis but also treatment. Reports indicate that minority and low-income populations often lack access to recommended care, despite advancements in cancer treatments.
The struggle to find resources and time for adequate care is prevalent. Many Americans report financial barriers to healthcare, and enrollment in Medicaid and the Affordable Care Act has decreased significantly. This situation negatively impacts access to necessary cancer care.
Support Systems and Future Concerns
Patient navigation programs have proven successful in assisting patients through cancer treatment barriers. These programs use navigators to guide patients through the healthcare system and ensure they attend vital appointments.
Nonetheless, the potential reduction in funding for such initiatives raises concerns. Proposed cuts to the NIH budget and the potential elimination of the National Institute of Minority and Health Disparities threaten progress in addressing cancer disparities, according to report chair Mariana Stern.
Leave a Reply